JNJ · News · 20260804N

Capital Return Program

JOHNSON & JOHNSON · 2026-08-04 · Importance 44 · Surprise 24

Johnson & Johnson returned $85 billion to shareholders during the past five years through dividends and share buybacks. The amount represents a material use of capital relative to the company's $25.31 billion revenue threshold. The reported shareholder returns occurred while the Innovative Medicine division was described as strong and the MedTech division was characterized as struggling. The capital-return history is therefore relevant to evaluating cash deployment alongside segment performance.

Key facts

• Johnson & Johnson has returned $85 billion to shareholders over the past five years through dividends and buybacks. source